363 related articles for article (PubMed ID: 27866679)
1. [Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].
Garciaz S; Coso D; Brice P; Bouabdallah R
Bull Cancer; 2016 Dec; 103(12):1035-1049. PubMed ID: 27866679
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
3. Health Disparities and the Global Landscape of Lymphoma Care Today.
Phillips AA; Smith DA
Am Soc Clin Oncol Educ Book; 2017; 37():526-534. PubMed ID: 28561692
[TBL] [Abstract][Full Text] [Related]
4. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
5. [New therapeutic strategies in non-Hodgkin lymphomas and Hodgkin lymphoma].
Rossi C; Bastie JN
Rev Med Interne; 2019 Apr; 40(4):246-254. PubMed ID: 29801709
[TBL] [Abstract][Full Text] [Related]
6. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science.
Hochberg J; Waxman IM; Kelly KM; Morris E; Cairo MS
Br J Haematol; 2009 Jan; 144(1):24-40. PubMed ID: 19087093
[TBL] [Abstract][Full Text] [Related]
7. Advances in the diagnosis and treatment of childhood and adolescent B-cell non-Hodgkin lymphoma.
El-Mallawany NK; Cairo MS
Clin Adv Hematol Oncol; 2015 Feb; 13(2):113-23. PubMed ID: 25774481
[TBL] [Abstract][Full Text] [Related]
8. Primary mediastinal large B-cell lymphoma.
Martelli M; Ferreri A; Di Rocco A; Ansuinelli M; Johnson PWM
Crit Rev Oncol Hematol; 2017 May; 113():318-327. PubMed ID: 28318892
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
10. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.
Minard-Colin V; Brugières L; Reiter A; Cairo MS; Gross TG; Woessmann W; Burkhardt B; Sandlund JT; Williams D; Pillon M; Horibe K; Auperin A; Le Deley MC; Zimmerman M; Perkins SL; Raphael M; Lamant L; Klapper W; Mussolin L; Poirel HA; Macintyre E; Damm-Welk C; Rosolen A; Patte C
J Clin Oncol; 2015 Sep; 33(27):2963-74. PubMed ID: 26304908
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of cancer patients with a compression mediastinal syndrome].
Zmeul VK
Vopr Onkol; 1971; 17(11):90-2. PubMed ID: 4945609
[No Abstract] [Full Text] [Related]
13. Primary mediastinal large B-cell lymphoma.
Bhatt VR; Mourya R; Shrestha R; Armitage JO
Cancer Treat Rev; 2015 Jun; 41(6):476-85. PubMed ID: 25913715
[TBL] [Abstract][Full Text] [Related]
14. Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?
Dunleavy K; Wilson WH
Blood; 2015 Jan; 125(1):33-9. PubMed ID: 25499450
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma in Adolescents and Young Adults.
Brugières L; Brice P
Prog Tumor Res; 2016; 43():101-14. PubMed ID: 27595360
[TBL] [Abstract][Full Text] [Related]
16. [Lisocabtagene maraleucel CAR-T cells - second line treatment in patients with relapsed or refractory large B cell lymphoma].
Chanut M; Herbaux C
Bull Cancer; 2023 Oct; 110(10):986-988. PubMed ID: 37661551
[No Abstract] [Full Text] [Related]
17. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
Forlenza CJ; Chadburn A; Giulino-Roth L
J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
[TBL] [Abstract][Full Text] [Related]
18. Transformative Clinical Trials in Non-Hodgkin and Hodgkin Lymphomas.
Abramson JS
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S141-6. PubMed ID: 26297267
[TBL] [Abstract][Full Text] [Related]
19. Should adolescents with NHL be treated as old children or young adults?
Sandlund JT
Hematology Am Soc Hematol Educ Program; 2007; ():297-303. PubMed ID: 18024643
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
